Company intelligence / Profile preview

Monacum Partners

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Monacum Partners is a private equity firm specializing in acquiring, repositioning, and revitalizing underperforming European SMEs, especially in industrial goods and business services. While their primary business is not life science, biotech, pharma, or healthcare, they have acquired assets in these areas, notably Evotec Drug Substance (Germany) GmbH, now operating as DAPIN GmbH, which is a pharmaceutical API and intermediates business.

Industry: Investors

Beyond the preview

Go deeper on Monacum Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monacum Partners.

Explore the full profile